Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

PDL BioPharma

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs.

GSK preps filings for BCMA-targeting multiple myeloma drug

GSK preps filings for BCMA-targeting multiple myeloma drug

GSK2857916 is one of a slew of BCMA-targeting therapies coming through the biopharma industry pipeline, jostling for position with a CAR-T therapy from Celgene and Bluebird Bio called bb2121 ... It is the most advanced BCMA-targeting ADC in development,

BeiGene gets speedy US review for lymphoma drug zanubrutinib

BeiGene gets speedy US review for lymphoma drug zanubrutinib First US filing is major milestone for Chinese firm. Chinese biopharma company BeiGene has claimed priority review status for its BTK inhibitor zanubrutinib from the FDA, setting up a possible approval

AstraZeneca buys FDA priority review voucher from Sobi

AstraZeneca buys FDA priority review voucher from Sobi Picks up coveted voucher for $95m. AstraZeneca has paid Swedish biopharma company Sobi $95m in cash for an FDA priority review voucher (PRV), which could help cut four months off the

Lilly’s Levi Garraway will replace Sandra Horning as Roche CMO

Lilly’s Levi Garraway will replace Sandra Horning as Roche CMO The CMO job at Roche is a prestigious one, with responsibility for making the most of one of the biggest R&D budgets in the biopharma industry at more than $11bn

AZ claims first-in-class win for Farxiga in heart failure

AZ claims first-in-class win for Farxiga in heart failure Mene Pangalos. The company’s head of biopharma R&D, Mene Pangalos, said that at the moment “half of heart failure patients will die within five years of diagnosis and it

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics